CD8A and oral lichen planus: Overall, these findings indicate that CAN296 effectively suppresses key cytotoxic markers in CD8+ T cells—on par with TAC and DEX—and remains consistently potent even at lower doses, supporting its potential therapeutic application in immune-mediated diseases such as OLP and oGVHD.